Akèy › Mediloblastom
Etid klinik pou Mediloblastom ap rekrite nan Etazini
24 etid pou Mediloblastom ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC9 etid
- St. Louis, MO6 etid
- Seattle, WA4 etid
- Houston, TX4 etid
- Miami, FL4 etid
- Durham, NC4 etid
- Philadelphia, PA4 etid
- New York City, NY4 etid
- Tampa, FL4 etid
- Boston, MA3 etid
- Columbus, OH3 etid
- Ann Arbor, MI3 etid
- Chicago, IL3 etid
- Cincinnati, OH3 etid
- Dallas, TX3 etid
- Austin, TX3 etid
- San Francisco, CA3 etid
- Minneapolis, MN3 etid
- Hartford, CT3 etid
- Charlotte, NC3 etid
- Orlando, FL3 etid
- San Diego, CA3 etid
- Little Rock, AR3 etid
- St. Petersburg, FL3 etid
- Memphis, TN3 etid
- Mountain View, CA3 etid
Pa eta
- Alabama3 etid
- Arkansas3 etid
- Connecticut3 etid
- Distrik Columbia7 etid
- Florid6 etid
- Georgia3 etid
- Illinois3 etid
- Kalifòni6 etid
- Kentucky3 etid
- Maryland4 etid
- Massachusetts3 etid
- Michigan4 etid
- Minnesota3 etid
- Missouri6 etid
- New Jersey3 etid
- New York5 etid
- North Carolina4 etid
- Ohio3 etid
- Pennsylvania5 etid
- Tennessee5 etid
- Texas8 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Ap rekriteFaz 1/2
Laj 1 a 25 · Tout sèks · Mizajou Sep 28, 2026 · NCT07346157Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback
Ap rekrite
Laj 10 a 25 · Tout sèks · Mizajou Sep 23, 2026 · NCT07830134Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Ap rekriteFaz 2
59 Months · Tout sèks · Mizajou Sep 15, 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Sep 11, 2026 · NCT07087002Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Ap rekriteFaz 2
Jiska laj 19 · Tout sèks · Mizajou Sep 10, 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
Ap rekriteFaz 1
Laj 2 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT07390539Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
Ap rekriteEtid obsèvasyon
Laj 3 a 50 · Tout sèks · Mizajou Sep 1, 2026 · NCT07242963Digoxin Medulloblastoma Study
Ap rekriteFaz 2
12 Months – 30 Years · Tout sèks · Mizajou Aug 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Ap rekriteFaz 3
Laj 4 a 21 · Tout sèks · Mizajou Aug 25, 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Ap rekriteFaz 2
Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Ap rekriteFaz 2
Jiska laj 21 · Tout sèks · Mizajou Aug 12, 2026 · NCT04696029PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Ap rekriteFaz 1/2
Laj 18 a 120 · Tout sèks · Mizajou Aug 12, 2026 · NCT06161519Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Ap rekrite
12 Months – 39 Years · Tout sèks · Mizajou Aug 11, 2026 · NCT05057702Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
Ap rekriteFaz 1
Laj 4 a 30 · Tout sèks · Mizajou Aug 7, 2026 · NCT06514898Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Ap rekriteFaz 1
Laj 2 a 25 · Tout sèks · Mizajou Aug 3, 2026 · NCT06624371Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Ap rekriteFaz 1/2
Laj 4 a 39 · Tout sèks · Mizajou Jul 20, 2026 · NCT05278208A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
Ap rekriteFaz 1
Laj 3 a 22 · Tout sèks · Mizajou Jul 13, 2026 · NCT07698899CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT07085325Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Jun 17, 2026 · NCT06193759Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Ap rekriteFaz 1
Laj 1 a 26 · Tout sèks · Mizajou Apr 13, 2026 · NCT04185038Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Ap rekriteFaz 1
Laj 3 a 25 · Tout sèks · Mizajou Jan 9, 2026 · NCT05106296Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT0454108268-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Ap rekriteFaz 4
Laj 18 a 100 · Tout sèks · Mizajou Nov 21, 2025 · NCT04081701Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.